Li, C. (2026) “Should CRISPR-Cas9 Be Used in Human Embryos to Eliminate Genetic Diseases? Public Attitudes and Benefit–Risk Analysis”, MedScien, 4(1), p. 6812. doi: 10.61173/as39n470.